Heart failure with preserved ejection fraction

HFpEF stands for heart failure with preserved ejection fraction, which is a type of heart failure in which the heart pumps normally but has difficulty relaxing and filling with blood. The American College of Cardiology (ACC) provides guidelines for the treatment of HFpEF. Here are some of the key recommendations:

Lifestyle modifications: Patients with HFpEF should be encouraged to make lifestyle modifications, such as losing weight if overweight or obese, increasing physical activity, reducing salt intake, and limiting alcohol consumption.

Management of comorbidities: Patients with HFpEF often have other medical conditions that can contribute to heart failure, such as hypertension, diabetes, and atrial fibrillation. These conditions should be managed appropriately.

Diuretics: Diuretics may be used to manage fluid overload in patients with HFpEF, but should be used with caution to avoid hypotension and electrolyte imbalances.

Beta blockers: Beta blockers may be used to manage symptoms in patients with HFpEF, but should be used with caution in patients with low blood pressure or bradycardia.

Calcium channel blockers: Calcium channel blockers may be used to manage hypertension in patients with HFpEF.

ACE inhibitors and ARBs: These medications may be used in patients with HFpEF who also have hypertension or diabetes.

Nitrates: Nitrates may be used to manage symptoms in patients with HFpEF, but should be used with caution in patients with low blood pressure.

Ivabradine: Ivabradine may be used in patients with HFpEF who have symptoms despite optimal medical therapy.

It's important to note that these guidelines are not one-size-fits-all, and treatment decisions should be tailored to each individual patient's needs and medical history. Patients with HFpEF should work closely with their healthcare providers to develop a treatment plan that works best for them.